Skip to Content

Olstein All Cap Value C OFALX

Medalist Rating as of | See Olstein Investment Hub
  • NAV / 1-Day Return 19.05  /  +0.58 %
  • Total Assets 549.4 Mil
  • Adj. Expense Ratio
    2.160%
  • Expense Ratio 2.160%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Large Value
  • Investment Style Mid Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.12%
  • Turnover 32%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0

Morningstar’s Analysis OFALX

Will OFALX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Olstein All Cap Value C earns a Morningstar Medalist Rating of Negative with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OFALX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 17.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

U.S. Bank Money Market Deposit Account

8.41 48.5 Mil
Cash and Equivalents

The Walt Disney Co

2.59 14.9 Mil
Communication Services

Sensata Technologies Holding PLC

1.80 10.4 Mil
Technology

CVS Health Corp

1.78 10.3 Mil
Healthcare

ABM Industries Inc

1.75 10.1 Mil
Industrials

SS&C Technologies Holdings Inc

1.74 10.0 Mil
Technology

U.S. Bancorp

1.67 9.6 Mil
Financial Services

Johnson & Johnson

1.65 9.5 Mil
Healthcare

Baxter International Inc

1.65 9.5 Mil
Healthcare

International Flavors & Fragrances Inc

1.64 9.5 Mil
Basic Materials